Skip to main content

Table 2 Results to docetaxel plus doxorubicin neoadjuvant chemotherapy

From: Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy

Response

No. of Pts (%)

Histopathologic response

 

   Pathologic complete response

4 (5.1)

   Minimal residual disease

10 (12.8)

   Gross residual disease

64 (82.1)